Advances in DNA and mRNA-Based Strategies for Cancer Immunotherapy

Arun Kumar Singh, M. Pharm (Pharmaceutics) from Galgotias University, India, is an Assistant Professor at Amity Institute of Pharmacy, Amity University, India. His research interests include biopolymers, nanoformulation, and the application of nanotechnology in cancer treatment. He has authored multiple book chapters and articles within the field of cancer therapy and related biomaterials. Dr. Neeraj Mishra is a Professor and Head of the Department of Pharmaceutics at Amity Institute of Pharmacy, India, a position he has held since July 2019. With nearly two decades of teaching and research experience, Dr. Mishra has authored over 100 publications on novel drug delivery systems, focusing on nanocarriers and microparticles for treating breast and colon cancer, as well as neurodegenerative disorders. He has written several books and book chapters, and holds three international and two Indian patents. Dr. Mishra has received numerous accolades, including the "Distinguished Professor Award" (2019, 2021) and the "Outstanding Scientist Award" (2020). He has served as a guest editor for Bentham Sciences and is recognized in Stanford University's World Scientists Rankings for 2022 and 2024. Sumel Ashique has been working as an assistant professor at Bengal College of Pharmaceutical Sciences & Research, Durgapur 713212, West Bengal, India, West Bengal, India. He has several years of teaching experience. He has achieved 70+ publications of International and national accredited reputed journals (Scopus, UGC). He has knowledge in drug delivery, nanotechnology and targeted treatment strategy. He has also several granted patents from IP and Australia, a dozen published book chapters in International Books. Dr. Pranav Kumar Prabhakar is currently working as a Professor and Deputy Director at Parul University, Punjab, India. He is one of the World’s Top 2% Scientists (list published by Stanford University, USA, 2021, 2022, 2023, and 2024). He has completed his PhD in Biotechnology from IIT Madras. His main area of research interest focuses on elucidating molecular Mechanisms and Strategies for Oral Insulin Delivery, Mimicking the signaling pathways in Metabolic Disorders (diabetes) with Natural Products. He is a member of the Royal Society of Chemistry, and the Asia-Pacific Chemical, Biological& Environmental Engineering Society. He is also serving as an editorial board member and reviewer for many reputed national and International Journals. Dr. Pranav received honors including the recipient of a travel grant towards attending ATTD 2009 in Greece from the Indian Institute of Technology Madras & Council for Scientific and Industrial Research (CSIR) and approved by the Department of Science and Technology (DST). He has published 100+ research articles in journals, authored 8 books, and 25 book chapters. He also delivered 9 oral and poster presentations in scientific meetings.

1. DNA and mRNA vaccines: Significant therapeutic approach against cancer management.
2. Nanoparticles for mRNA-based cancer immunotherapy
3. Nucleic acid Delivery as a therapeutic approach in cancer immunotherapy
4. Plasmid DNA and mRNA: Delivery approaches and challenges
5. Viral & Non-viral Delivery of mRNA against Cancer Cell
6. Progress in Modifying and Delivering mRNA therapies for Cancer Immunotherapy
7. mRNA-Based Cancer Vaccines: A Novel Approach to Melanoma Treatment
8. Therapeutic mRNAs for cancer immunotherapy: from structure to delivery
9. Harnessing the immune system: Insights into cancer vaccines
10. Lipid Nanoparticle-Mediated mRNA Delivery in Cancer Immunotherapy
11. Immunotherapy Perspectives in the Era of B-Cell Editing in Cancer Treatment
12. Personalized Precision: Revolutionizing Cancer Treatment with mRNA-Based Vaccines in Melanoma Therapy
13. Revolutionizing Cancer Treatment: Exploring Novel Immunotherapeutics, Checkpoints, bispecifics, and Vaccines in Development
14. Recent progress, challenges (stability and in vivo distribution), and opportunities of DNA and mRNA Vaccine in cancer Immunotherapy